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Abstract Connexins form a family of transmembrane proteins that consists of 20members in humans and 21members inmice. Six
connexins assemble into a connexon that can function as a hemichannel or connexon that can dock to a connexon
expressed by a neighbouring cell, thereby forming a gap junction channel. Such intercellular channels synchronize
responses in multicellular organisms through direct exchange of ions, small metabolites, and other second messenger
molecules between the cytoplasms of adjacent cells. Multiple connexins are expressed in the cardiovascular system.
These connexins not only experience the different biomechanical forces within this system, but may also act as effector
proteins in co-ordinating responses within groups of cells towards these forces. This review discusses recent insights
regarding regulation of cardiovascular connexins by mechanical forces and junctions. It specifically addresses effects of
(i) shear stress on endothelial connexins, (ii) hypertension on vascular connexins, and (iii) changes in afterload and the
composition of myocardial mechanical junctions on cardiac connexins.
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1. Connexins in the cardiovascular
system
Connexins form a family of transmembrane proteins that consists of 20
members in humans and 21 members in mice. Oligomerization of six
connexins results in the formation of a connexon. Such a connexon
can dock to a connexon expressed by a neighbouring cell, thereby
forming a gap junction channel.1 These channels are crucial for gap junc-
tional intercellular communication (GJIC) as they allow passage of small
molecules from the cytosol of one cell to another. Classically, ions and
metabolites ,1000 Da, e.g. ATP, Ca2+, cAMP, and IP3, are known to
pass through gap junction channels. But larger molecules, such as pep-
tides and small nucleotides, have also been shown to be able to diffuse
through gap junctions.2–4 In addition, a connexon can also function as
a hemichannel and allow diffusion of molecules between the cytoplasm
and the extracellular space.5
The most abundantly expressed connexins in the cardiovascular
system are connexin37 (Cx37), Cx40, Cx43, and Cx45. The expression
of these proteins displays a large heterogeneity throughout the circula-
tory system (i.e. arteries, veins, lymphatic vessels, and the heart). In the
vessels of healthy subjects, endothelial cells (ECs) of large conduit arter-
ies expressCx37 andCx40,whereasCx43and (to amuch lowerextent)
Cx45 aremostly expressedby vascular smoothmuscle cells (VSMCs).6,7
The level andpatternof connexin expression in conduit arteries changes
with age and during atherogenesis,6,8 suggesting that connexins may be
contributing to the latter process. In the apolipoprotein-E-deficient
(ApoE2/2) mouse model for atherosclerosis, it has indeed been
shown that Cx37 and Cx40 display atheroprotective properties,9,10
whereas Cx43 appeared pro-atherogenic.11 Recently, both Cx37 and
Cx40 have been described to interact with endothelial nitric oxide syn-
thase (eNOS) in aortic ECs.12,13 This suggests that both Cx37 andCx40
may regulate release of eNOS-derived nitric oxide (NO). In agreement
with these findings, it has been shown that Cx40-deficient (Cx402/2)
mice, which are also characterized by a reduced endothelial Cx37 ex-
pression, display diminished agonist-induced endothelium-dependent
vasodilatation.12 In addition, in vitro evidence suggests that Cx37 inhibits
eNOS-dependent NO production.13 However, arteries from Cx37-
deficient mice (Cx372/2) exhibit proper endothelium-dependent
relaxation ex vivo.14 Compared with conduit arteries that fully depend
on NO for endothelium-dependent relaxations, smaller blood vessels
typically depend largely on endothelium-derived hyperpolarization for
endothelium-mediated control of vascular tone.15 Interestingly, ECs
and VSMCs of small muscular resistance arteries express Cx37, Cx40,
and Cx43.16,17 In these arteries, connexins are involved in the spreading
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of endothelium-dependent vasodilatation and relaxation induced by
endothelium-derived hyperpolarizing factor(s).18,19 ECs of large veins
have been described to express Cx37, Cx40, and Cx43,20 although
Cx40 and Cx37 expression levels seem lower than those of the
aorta.21 Finally, lymphatic ECs express Cx37, Cx43, and Cx47,22,23
and recently Cx37 has been shown to be of crucial importance for the
formation of lymphatic valves;22,23 i.e. Cx372/2 mice lack lymphatic
valves and therefore display reduced lymph flow.22,23 More recently,
Cx37 has been reported to be critically involved in the formation of
venous valves as well.24
Classically, connexins expressed by the working myocardium con-
tribute to synchronization of cardiac contractions by electrically coup-
ling cardiomyocytes. However, cardiac connexins can also play a
deleterious role, e.g. after periods of ischaemia by passing so-called
‘death signals’ from one cardiomyocyte to the next.25,26 Healthy ven-
tricular myocardium mainly expresses Cx43 and, to a lesser extent,
Cx45, and healthy atrial myocardium expresses high levels of both
Cx40 and Cx43 in addition to small amounts of Cx45.25 Cells that
form the electrical conduction system responsible for the rapid
spread of electrical signals from the sinoatrial node towards the ventri-
cles have been described to express a variety of connexins (i.e. Cx45,
Cx43, Cx40, and Cx30). The particular set of connexins expressed by
these cells is strongly dependent on their location.27 In summary, mul-
tiple connexins are expressed in the cardiovascular system that not
only experience the different biomechanical forces within this system,
but may also act as effector proteins in co-ordinating responses within
groups of cells towards these forces.
2. Effect of shear stress in arteries
It is increasingly recognized that the endothelium lining the cardiovascu-
lar system is highly sensitive to haemodynamic shear stresses, which act
at the vessel luminal surface in the direction of blood flow. Wall shear
stress, the frictional force between blood and the endothelium, is
more and more recognized as a key determinant of EC function, gene
expression, and structure.28 In this respect, Kru¨ppel-like factor 2
(KLF2) and nuclear factor-E2-related factor-2 (Nrf2) transcription
factors have been identified as central regulators of physiological
responses to arterial shear stress.29 In straight portions of arteries,
KLF2 is induced in ECs exposed to prolonged high laminar shear
stress (HLSS) where it regulates the expression of anti-inflammatory
and anti-coagulant proteins, such as eNOS and thrombomodulin.
HLSS also activates Nrf2, a transcription factor that regulates redox
levels by induction of numerous anti-oxidant enzymes such as heme
oxygenase-1. Physiological variations in shear stress regulate acute
changes in bloodvessel diameter and,when sustained, induce slowadap-
tive vascularwall remodelling.As aconsequence, atherosclerotic lesions
develop predominantly near side branches of arteries, i.e. where blood
flow is oscillatory, or at the lesser curvature of bends of the arterial tree,
i.e. where blood flow rates are relatively low.30 ECs in these areas of low
or oscillatory shear stress (OSS) display activation of nuclear factor kB
(NFkB) and activationprotein 1 transcription factors, resulting in the ex-
pression of pro-inflammatory genes such as vascular cell adhesion
molecule-1 (VCAM-1), E-selectin, and interleukin-8 (IL-8).31 In brief,
the arterial endothelium is continuously exposed to regional differences
in shear stress, which induces differential transcriptional activity in
adjacent territories.
3. Connexins as effector proteins in
co-ordinating shear stress responses?
Intercellular channels formed by connexins provide a simple method of
synchronizing responses in multicellular organisms through direct ex-
change of ions, small metabolites, and other second messenger mole-
cules between adjacent cells.32,33 This type of intercellular signalling is
implicated in rapid co-ordinated activities such as contraction of the
heart.34 In contrast, GJIC has to be restricted between adjacent territor-
ieswithdifferent functionoractivationstate.Gap junctions in the arterial
endothelium are known to consistmainly of Cx40 andCx37.7,35 Cx43 is
moderately expressed or absent in the quiescent arterial endothelium,
but is induced under conditions associatedwith endothelial dysfunction.
Gabriels andPaul36 observed thatCx43wasnotdetectable inmostparts
of the rat aorta but very abundant in small clusters of cells localized at the
downstream edge of ostia of branching vessels or flow dividers. More-
over, when they created flow disturbances in vivo by surgical coarctation
(by ligature) of the aorta leading to a 30% reduction in vessel diameter,
increased Cx43 expression was observed in areas of pronounced oscil-
latory flow, whereas Cx40 expression levels were unchanged by this
treatment. In contrast, Cx37 expression seemed down-regulated in
these regions and very little co-expression of Cx37 and Cx43 was
observed.Although aortic coarctationwill induce significant flowdistur-
bances, an effect of arterial compressiononconnexin expression cannot
be completely ruled out using this model. It is, therefore, interesting that
the relationbetween shear stress andconnexin expressionhas alsobeen
investigated on upstream and downstream surfaces of rat cardiac valves
that are naturally subjected to very different intensities of shear stress.37
The authors observed up to 200-fold greater expression of Cx43 in the
ECs on the upstream compared with the downstream surfaces. In con-
trast, Cx37 expression was equal in both endothelia and Cx40 was not
detected at all. Although ECs covering cardiac valves are also exposed to
highpressures, it remainsdifficult to compare thesecellswith the arterial
endothelium, given their different haemodynamic environment.
In addition to these early in vivo studies, several in vitro studies have
been performed to investigate the correlation between Cx43 expres-
sion and different biomechanical forces on various types of ECs. In a
first preliminary report,38 a four-fold increase in Cx43 mRNA levels in
porcine aortic ECs was reported already after 1 h of 15 dynes/cm2
LSS, which remained elevated for the complete investigated period
(24 h). This report was followed by a sophisticated and detailed
study39 in which the spatial and temporal regulation of Cx43 mRNA
and protein as well as intercellular communication was mapped in
monolayers of bovine aortic ECs exposed to controlled flowconditions.
At short term (5 h), endothelial Cx43was increased under conditions of
both laminar flow and in areas of flow separation and recirculation com-
pared with no-flow controls. However, after 16 and 30 h of shear
stress, Cx43 expression remained increased in cells subjected to dis-
turbed flow, but Cx43 expression returned to normal levels in regions
of undisturbed laminar flow. The differences in Cx43 expression were
matched by an increased level of intercellular spread of Lucifer
Yellow, a Cx43-permeable dye, in the region of disturbed flow. The
effects of pulsed unidirectional and OSS in combination with different
levels of hydrostatic pressure and circumferential stretch on Cx43 ex-
pression was investigated in PymT-transformed mouse ECs (bEnd.3),
expressing all the three endothelial connexins, that were grown to
confluence on the inside of elastic tubes.40 Interestingly, increased
Cx43 expression was observed after 24 h of modest levels of both
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pulsatile LSS and OSS, although the rise in Cx43 expression reached
higher levels (up to three-fold) under OSS. In addition, 4% (change of
diameter) circumferential stretch caused a significant increase in Cx43
protein levels after 4 h that remained elevated after 24 h. In contrast,
raising pressure from 100 to 150 mmHg for up to 24 h had no effect
on Cx43 expression in ECs. Altogether, these studies provide clear evi-
dence that endothelial Cx43 expression is sensitive to changes in the
haemodynamic environment, in particular to OSS. Although NFkB
andmitogen-activatedproteinkinasepathwaysare likely candidates,41,42
the mechanism by which OSS induces Cx43 expression in arterial ECs
still remains to be established.
As mentioned before, most ECs in the aorta express high levels of
Cx37, but this expression is lost in ECs at bifurcations and in ECs over-
lying atherosclerotic plaques.6An increasing numberof largemicroarray
data sets have become available in which gene expression patterns in
various shear stress regions have been compared with each other or
to static culture conditions. These microarrays have provided rather in-
consistent data regarding the regulation of endothelial Cx37 expression
by shear stress.43–46 As described above, HLSS is known to be vaso-
protective through the induction of KLF2. As the promoter region of
the Cx37 gene contains many KLF consensus binding sites, we hypothe-
sized that shear stress, throughmodulation of KLF2, may regulate Cx37
expression in the arterial endothelium. Using 16-week-old atherosus-
ceptibleApoE2/2mice,wefirst confirmed thatCx37 is highly expressed
in the straight region of the common carotid artery of these mice,
whereas it is reduced at the carotid bifurcation.47 The differences in
Cx37expressionwere accompaniedby a decreased level of intercellular
spread of propidium iodide, a Cx37-permeable dye, in the bifurcation
region. We then used shear stress-modifying vascular devices that
impose specific flow patterns in mouse carotid arteries.48 We found
that Cx37 expression was down-regulated in regions of altered flow
(either LLSS orOSS), but was conserved in regions of HLSS (Figure 1).47
To further study themechanisms involved, bEnd.3or humanumbilical
veinECs (HUVECs)wereexposed to shear stress in vitro. Cx37andKLF2
expression were increased after 24 h of HLSS (25 dynes/cm2). Interest-
ingly, Cx37 expressionwas reduced after silencing KLF2, suggesting that
KLF2 indeed acts as a transcription factor for this gap junction protein.
Moreover, binding of KLF2 to the promoter region ofCx37was demon-
strated by chromatin immunoprecipitation. We finally used a scrape-
loading dye transfer approach and determined that gap junctional
permeability to propidium iodide was severely impaired following
KLF2 silencing in a monolayer of ECs. Altogether, this study demon-
strated that shear stress, by modulating KLF2 expression, forms distinct
communication compartments in arteries, with atherosusceptible
regions expressing less Cx37 and displaying less intercellular diffusion
of the cationic dye propidium iodide than the protected regions.47
This compartmentalization could, for example, be beneficial by limiting
spread of specific pro-inflammatory mediators away from the region
subjected to disturbed flow. On the other hand, shear stress-induced
Cx37 may be involved in synchronizing endothelial responses to
protective circulating factors.
Cx37 is also expressed in lymphatic ECs. However, in contrast to the
arterial endothelium, its expression is mostly limited to regions of valve
formation that are exposed to (low)OSS.23 Interestingly, recent studies
demonstrated a severe impairment of lymphatic valve formation and
function in Cx372/2 mice.22,23 Based on in vitro studies in which lymph-
atic ECs were exposed to physiological values of OSS, the authors
proposed a mechanism for lymphatic valve formation in which Cx37
acts downstream of the lymphatic endothelial transcription factors
Prox1/Foxc2 and shear stress, leading to a synchronized calcineurin/
nuclear factor of activated T-cells (NFAT) activation in response to
flow.23 Mechanistically, Cx37 gap junctions may mediate transfer of
IP3, which triggers release of intracellular Ca
2+ necessary for calci-
neurin/NFAT activation. However, involvement of other second mes-
senger pathways cannot be excluded. Although the effector role of
Cx37 in forming communication compartments in the lymphatic or ar-
terial endothelium is similar, it remains very intriguing that the signalling
pathways inducing the expression of the effector protein are dependent
on a different, almost opposite, typeof shear stress that up-regulates dis-
tinct transcription factors. Of note, Cx372/2 mice also lack venous
valves.24 And although the mechanism of Cx37 expression in venous
valveshasnotbeen investigatedyet, onecan imagine that similarmolecu-
lar pathways control valve development in veins and lymphatic vessels,
since they share a common embryonic origin.
Cx40 expression in the endothelium of large arteries seems to have
little sensitivity to flow disturbances. Indeed, Cx40 expression is high in
the straight portion of the mouse carotid artery and seems unaltered at
the carotid bifurcation.47 Moreover, Cx40 expression levels in the
mouse aortic ECs were not affected by surgical coarctation.36 Similar
to KLF2, KLF4 transcription is induced in arteries by HLSS and this
transcription factor subsequently regulates the expression of (vaso-
protective) target genes. Interestingly, Cx40 mRNA expression in
cultured ECs was moderately down-regulated by KLF4 siRNA, while
it remained unaffected by KLF2 silencing.47 Whether arterial Cx40
expression is directly regulated by KLF4 or whether additional shear
stress-responsive transcription factors are involved remains to be
investigated.
More mechanistic details on the relation between shear stress and
Cx40 are available from studies in the microvasculature, where shear
stress causes a long-term induction of Cx40 protein expression. This
Cx40 expression is greatly reduced by inhibiting PI3 kinase or Akt,
with PI3K activity being required for basal Cx40 expression and Akt ac-
tivity taking part in shear stress-dependent induction of Cx40.49 As
endothelial Cx40 plays an important role in signal propagation along
the wall of arterioles,35,50 this induction of Cx40 expression may have
important functional consequences for the adaptation of microvascular
networks.
Arterial pressure fluctuates as a result of the rhythmic activity of the
heart. The effects of constant and pulsatile shear on the expression of
arterial identity genes have been investigated by using a combination
of approaches ranging from in vitro ECs cultures, the developing
chicken embryo yolk sac vasculature, and mouse occlusion models. Re-
cently, Buschmann et al.51 elegantly demonstrated that a combination of
pulsatile shear andCx40 is of critical importance for arterial identity and
remodelling events during flow-driven arteriogenesis.
Altogether, the presently available studies point to a strong function
for Cx40 in endothelial synchronization of mechanosensitive responses
in the microvasculature, whereas Cx43 and Cx37 seem crucial for
mechanosensitive compartmentalization in the arterial and lymphatic
endothelium.
4. Hypertension and connexins
Hypertension is a chronic disease that can be subdivided in systemic
hypertension and pulmonary hypertension. Systemic hypertension is
estimated to affect up to one-third of the Western population and
likely accounts for 16% of all deaths annually.52 The pathophysiology
underlying the majority of cases remains poorly understood and
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therefore this disease is defined clinically. Systemic hypertension is
defined as (i) a systolic blood pressure .140 mmHg or (ii) a diastolic
blood pressure .90 mmHg or (iii) normal blood pressure but on anti-
hypertensive therapy or (iv) being told at least twice by a health profes-
sional that one suffers from hypertension.52 Pulmonary hypertension
has been defined as a mean pulmonary arterial pressure .25 mmHg
at rest as assessed by right heart catheterization.53,54 Pulmonary hyper-
tension affects 10–20% of the general population and is more prevalent
in females compared with males.55–57
Connexins are widely expressed in organs involved in the pathogen-
esis of both systemic hypertension (e.g. ECs, VSMCs, and renin produ-
cing cells in the kidney) and pulmonary hypertension (e.g. pulmonary
artery ECs and pulmonary fibroblasts). In addition, connexins are
expressed in organs suffering from the consequences of both diseases
(e.g. the left ventricle, which experiences increased afterload during sys-
temic hypertension, and the right ventricle which is exposed to
increased afterload during pulmonary hypertension). Despite the fact
that many animal models have been used to study connexins in the
contest of systemic hypertension, there is surprisingly little consensus
regarding the effect of hypertension on connexin expression (for an
overview, see Table 1). In addition, the molecular mechanisms by
which hypertension affects connexins are largely unknown.
5. Connexins in renin- and
NO-dependent hypertension
Inmodels of renin-dependent hypertension [e.g. theDOCA-salt and the
2-kidney, 1-clipGoldblatt (2K1C)models], the expressionof bothCx40
andCx43 increases albeit in a vessel- and time-dependentmanner.41,58–
60 Although the expression of Cx40 increases in both kidneys in the
2K1C model, the expression of Cx43 only increases in the unclipped
kidney, suggesting that this increased Cx43 is a consequence of the
rise in intravascular pressure rather than a more general stimulus.61
Moreover, Cx43 but notCx40 increases in aortic VSMCs ofDOCA-salt
or 2K1C rats,61 whereas in mice these procedures induce an
up-regulation of both Cx43 and Cx37 in aortic VSMCs.41 It has, there-
fore, been suggested that Cx43 is particularly sensitive to the haemo-
dynamic changes that are associated with both models of
hypertension rather than being sensitive to renin that displays opposite
changes in these two animals models. This attractive suggestion has,
however, been undermined by the fact that Cx43 expression appeared
decreased in aortas fromrats suffering fromL-NAME-inducedhyperten-
sion.62,63 Thus, haemodynamic changes per se do not necessarily lead to
increased expression of Cx43 in aortic VSMCs. Importantly, decreased
Cx43 expression in L-NAME-induced hypertension was fully reversed
bya7-day treatmentwith thenon-selectivebeta-adrenergic blockercar-
vedilol, whereas treatment with the selective beta1-receptor antagonist
atenolol only partially reversed the effects of hypertension on Cx43
expression (although the reduction in blood pressure was similar
between the treatments), suggesting a blood pressure-independent
role for beta2-receptor agonism on Cx43 expression in VSMCs. Of
note, Cx40 expression was not altered by hypertension nor drug treat-
ment in any of the groups.63
6. Connexins in rat and mouse
models of genetic hypertension
In addition to studies focusing on changes in connexin expression in
models that depend on pharmacological (e.g. L-NAME-induced
hypertension) or surgical (e.g. the 2K1C model) interventions to
Figure 1 (A) High laminar shear stress is atheroprotective partly through induction of Kruppel-like factor 2 that, in turn, up-regulates Cx37 expression
and, therefore, ensures co-ordination of endothelial responses. Representative images of Cx37 (green) in the endothelium of carotid arteries exposed to
low laminar (B), high laminar (C) or oscillatory shear stress (D) in vivo. HLSS, high laminar shear stress; KLF2, Kruppel-like factor 2; LLSS, low laminar shear
stress; OSS, oscillatory shear stress; SSS, shear stress sensor.
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induce hypertension, connexin expression has also been studied in
spontaneously hypertensive rats (SHR). The endothelium lining caudal
arteries isolated from 3-week-old (i.e. the pre-hypertensive period)
SHR or Wistar Kyoto (WKY) control rats expresses similar amounts
of Cx37 and Cx43, whereas the expression of Cx40 is significantly
lower in SHR ECs.64 Moreover, the expression of Cx37, Cx40, and
Cx43was not affected by age in theWKY arteries. However, compared
with arteries isolated from 3-week-old pre-hypertensive SHR rats, the
expression of Cx37, Cx40, and Cx43 was significantly decreased in
the arterial endothelium of 12-week-old SHR.64 A more recent study
from the same group focused on the expression of connexins in the
aortic wall of pre-hypertensive and hypertensive SHR compared with
normotensive WKY.65 In this study, no differences were detected
between SHR and WKY aortas in the pre-hypertensive period.
However, aortas from hypertensive rats displayed reduced endothelial
Cx37 and Cx40 but increased expression of Cx37 and Cx43 in the
media.65 Mechanistically, treatment of SHR using an inhibitor of the
angiotensin-converting enzyme (ACE) normalized blood pressure and
connexin expression.65 However, since the study did not include a
control group in which blood pressure was lowered using an aspecific
vasorelaxant (e.g. hydralazine) it is unclearwhether this effect ofACE in-
hibition was a direct effect on connexin expression or an indirect effect
caused by a lower blood pressure. Indeed, an earlier study focusing on
the molecular mechanism that regulates the expression of connexins
inmesenteric arteries from SHR andWKY rats66 showed that endothe-
lial Cx37 and Cx40 expression was significantly lower, whereas Cx43
was significantly higher in SHR compared with WKY mesenteric arter-
ies. In this study, angiotensin receptor (AT) blockage reduced the
blood pressure of SHR, increased the expression of both Cx37 and
Cx40, and decreased the expression of Cx43. However, the
combination of hydralazine and hydrochlorothiazide lowered
thebloodpressure toa similarextent, but didnot correct theexpression
of eitherCx37orCx40,66 thus rulingout adirecteffect of loweredblood
pressure on connexin expression. Finally, connexin abundance has also
been studied in the renal resistance arteries of SHR andWKY rats.67 At
this location, Cx40 and Cx43 expression was similar for both strains of
rats. However, Cx37 was 2.4-fold decreased in SHR renal resistance ar-
teries. Renal resistance arteries from normotensive Sprague–Dawley
rats displayed equal Cx37 expression compared with SHR arteries sug-
gesting that the decreased Cx37 expression in the SHR arteries was not
due to the difference in blood pressure but was likely due to differences
between the strains of rats. Finally, the effect of hypertension on con-
nexin expression was studied in Cx402/2 mice.12,41,68,69 These mice
are hypertensive and are characterized by an increased expression of
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Table 1 Effect of hypertension on connexin expression in the cardiovascular system
Species Model Cx37 Cx40 Cx43 Cx45 Note Ref.
Rat SPSHR ND ND (mesenteric arterial cell
culture)
ND [112]
Rat DOCA-salt ND ND (aorta) ND [60]
Rat 2K1C ND ND (aorta),(cardiomyocyte) ND [58,59]
Rat DOCA-salt ND ND (aorta),(cardiomyocyte) ND [58,59]
Rat L-NAME ND ND (aorta),(cardiomyocyte) ND [62]
Rat 2K1C ND (both kidney) (unclipped kidney) ND [61]
Rat 3-week-old
SHR
(caudal ECs) (caudal ECs) (caudal ECs) ND [64]
Rat 12-week-old
SHR
(caudal ECs) (caudal ECs) (caudal ECs) ND [64]
Rat SHR (mesentric ECs) (mesenteric
ECs)
(mesenteric ECs) ND Candesartan increased
expression of Cx37 and Cx40










(aortic ECs) (aortic VSMCs) ND Normalized endothelial connexin
expression by ACE inhibition.
[65]




Mouse Cx402/2 (RSC) Undetectable (RSC) ND [68]





 (renal arteriolar ECs) ND [67]







(aortic VSMCs) (aortic ECs)  (whole aorta lysate) (aortic
VSMCs)
[41]
Mouse Cx402/2 (aortic VSMCs),
(aortic ECs)
Undetectable (aortic VSMCs) (aortic
VMCs)
Connexin expression in VSMCs
reduced by candesartan
[41]
ECs, endothelial cells; ND, not determined; RSC; renin-secreting cells; VSMCs, vascular smooth muscle cells.
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Cx37,Cx43, andCx45 in aortic VSMCs.41 Intriguingly, the expression of
Cx37 in ECs fromCx402/2mice is reduced,10,41,70 possibly pointing to a
common pathway for Cx40 and Cx37 in the transport towards the
plasma membrane. In contrast, the expression of Cx37 and Cx43 in
renin-secreting cells does not seem to be affected byCx40 deficiency.68
7. Role of Cx40 in hypertension
Despite all the above-mentioned data associating hypertension with
changes in connexin expression, evidence that connexins are actually
implicated in hypertensive disease was lacking for a long time and
came only from studies of Cx402/2 mice.12,41,68,69 It appeared that
Cx40 expression in renin-secreting cells in the kidney regulates their se-
cretionof renin (for an excellent review, seeBosco et al.32). Indeed,mice
ubiquitously deficient for Cx40 but also mice with specific deficiency of
Cx40 in renin-secreting cells display increased renin plasma concentra-
tions and are markedly hypertensive.68,71 Moreover, Cx402/2 mice
treated with an AT1 receptor antagonist or with an ACE inhibitor
show reduced blood pressure despite the fact that in these animals
renin plasma levels are even further increased (compared with untreat-
ed Cx402/2 mice).68,71 Interestingly, five somatic mutations in GJA5, the
human gene coding for Cx40, were reported in 2006.72 One of these
mutations, coding for an Ala96Ser substitution, results in the expres-
sion of a protein that localizes efficiently to the junctional plaque but is
unable to form functional channels.72 Surprisingly, the expression of
this Cx40 A96S mutation in C57BL6 mice caused renin-dependent
hypertension characterized by similar blood pressure increases as
observed in Cx402/2 animals.68,71,73 This suggests that actual GJIC
between renin-producing cells may be required for Cx40-mediated
control of renin release. However, a study from Kurtz et al.69 shows
that the mechanism by which Cx40 deficiency leads to increased
renin levels in mice lies in the structural changes that can be observed
in the juxtaglomerular apparatus of Cx402/2 mice and not a reduced
amount of GJIC communication.
GJA5wascloned in199474and itwasthereafter shownthatmutations in
the coding regionof this gene are associatedwith various cardiac arrhyth-
mias. Whether mutations in the coding region of GJA5 such as the Cx40
A96S are associated with hypertension in humans is currently unknown.
Genetic polymorphisms in the human Cx40 gene promoter leading to
reducedCx40expression have, however, beenbe associatedwith hyper-
tension already in 2006.75However, these results could not be confirmed
in a recent study.76 Thus, although the exact molecular mechanism is not
entirely clear and human data regarding the effect of mutations in the
coding region of GJA5 are missing, studies of genetically altered mice
have provided substantial evidence for a role of Cx40 in renin-dependent
hypertension. Of note, several studies have shown that the increased
blood pressure in Cx402/2 mice cannot be fully reversed by treating
the animals with either an AT1 antagonist or an ACE inhibitor.
68,71,77
Thus, additionalCx40-dependentpathwaysmaybe implicated inthe regu-
lation of blood pressure as well. In this regard, the fact that resistance
arteries from Cx402/2 mice display impaired conducted dilatations and
irregular vasomotion, possibly leading to increased peripheral vascular
resistance, is of particular interest.77–79
8. Effect of afterload on the heart
In the beating heart, cardiomyocytes are subjected to a constant cycle
of stretch and contraction. These mechanical forces regulate overall
cell and organ function, both in health and in disease. The coupling
of the contractile machinery of one cell with that of its neighbours
is essential both for effective contraction, and for preservation of
the elastic properties of the cardiac muscle. Molecular complexes
(desmosomes, adherens junctions, and area composita) integrate at
the site of cell contact (the intercalated disc) to provide a cell–cell
mechanical continuum. Also at the intercalated disc, gap junctions
allow for electrical synchrony between cells (Figure 2). When this elec-
trical synchrony is disrupted, as seen in disease states causing a
reduced and heterogeneous expression of Cx43, it predisposes to
electrical re-entry and ultimately to the development of possibly
fatal arrhythmias. While gap junctions and mechanical junctions
were originally described as separate and independent entities,
present data suggest that molecules classically defined as belonging
to one group (e.g. desmosomes) can greatly affect the integrity of
the other (e.g. gap junctions). The mechanisms responsible for this
cross-talk are a subject of intense research in the field.
The response of cardiomyocytes to mechanical load has been exten-
sively studied. Using monolayers of neonatal rat ventricular myocytes
(NRVMs), Zhuang et al.80 showed that unidirectional pulsatile stretch
up-regulates Cx43 expression. This connexin up-regulationwas accom-
paniedbyan increase in conduction velocity. Separate studies showedan
early and transient increase inCx43mRNAincardiomyocytes subjected
to pulsatile stretch.81,82 Thus, the regulation of Cx43 gene expression
could underlie the observed induction of this protein by pulsatile
stretch. However, a reduction of Cx43 protein degradation following
stretch could also be involved. In fact, it seems that stretch is able to
reduce contractile protein turnover inNRVMsunder specific conditions
of stretch degree and orientation.83 Whether a similar effect of stretch
onCx43 protein turnover also takes place remains to be demonstrated.
Several pathways seem to be involved in the regulation of Cx43 expres-
sion by mechanical forces. NRVMs release autocrine–paracrine factors
such as angiotensin II (Ang II), endothelin-1, vascular endothelial growth
factor (VEGF), and transforming growth factor-b (TGF-b).82,84–87Cx43
can be induced by exposure to VEGF or TGF-b and, more importantly,
stretch-dependent induction of Cx43 expression can be abolished by
antibodies directed against VEGF or TGF-b.88 In fact, early stretch-
induced up-regulation of Cx43 seems to be partially mediated by
VEGF, which acts downstream of TGF-b.88 Similarly, Ang II was shown
to induce Cx43 expression in vitro, and stretch-dependent induction of
Cx43 can be prevented by exposure to AT1 receptor antagonists
such as losartan.82 It, thus, appears that several soluble factors that
are released upon pulsatile stretch may promote GJIC between
cardiomyocytes.
In addition to Cx43, short periods of pulsatile stretch were demon-
strated to up-regulatemechanical junction proteins such asN-cadherin,
plakoglobin, and desmoplakin at cell–cell junctions.80,89 Moreover, the
degreeof stretch and themicro-architecture of the cell–cell contact de-
termine the formation of cell–cell adhesions. Indeed, pairs of NRVMs
cultured on deformable substrate show variable expression of mechan-
ical junction proteins depending on their shape (length-to-width ratio)
and the stiffness of the substrate.90 Interestingly, studies of freshly disso-
ciated adult rat ventricularmyocytes that are allowed to reformcell–cell
contact in culture showed that the formation of adherens junctions at
the intercalateddisc is a pre-requisite forCx43gap junction formation.89
In general, gap junction formation is seen as a process that occurs after
mechanical coupling between cells (see also Meyer et al.91). It, thus,
appears that, in vitro, mechanical stretch can also affect Cx43 expression
by modifying the expression and localization of mechanical junction
proteins.
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The overall consensus of in vitro studies is that mechanical stretch
favours Cx43 expression and GJIC in cardiomyocytes. Numerous
studies of animal models and human patients have aimed to investigate
the effect of stretch in vivo. Most studies involved increased left ventricu-
lar afterload, such as encountered with aortic stenosis in human or its
animal model, transverse aortic constriction (TAC), or increased right
ventricular afterload such as pulmonary hypertension. In an initial
study, monocrotaline-induced pulmonary hypertension in rats resulted
in the so-called remodelling of Cx43 expression, defined as a loss of gap
junctions at the centre of intercalated discs and a redistribution of Cx43
to the lateral membrane of cardiomyocytes 4 weeks after induction.92
Interestingly, the remodelling of Cx43 was similar in rats subjected to
TAC for 12 weeks.93 Thus, initial studies examining animals with
severe pulmonary hypertension or TAC-induced left ventricular hyper-
trophy seemed to be in contradiction with in vitro studies. Subsequent
studies that examined animals at different time-points after pressure
overload found a transient increase in Cx43 expression up to 5 days
after TAC, which was followed by a progressive decline in total expres-
sion.94 This biphasic response ofCx43 expression to increasedmechan-
ical stretch corroborates findings in patients suffering aortic stenosis;
Kostin et al.95 showed that in patientswith compensated aortic stenosis,
Cx43 expression is increased compared with healthy subjects and
the protein redistributes to the lateral membrane. However, in patients
suffering fromdecompensated aortic stenosis, the total amount ofCx43
and the number of gap junctions are severely reduced, with a heteroge-
neous pattern of expression within the myocardium. One can thus
postulate that the early increase and redistribution of Cx43 participates
in the compensatory mechanism of the myocardium to overcome
increased afterload. Once the compensatory mechanisms start to fail,
Cx43 expression is reduced and becomes heterogeneous, which in
turn can promote arrhythmias as seen in patients with decompensated
aortic stenosis and, possibly, with pulmonary hypertension.96
The mechanisms leading to Cx43 remodelling are becoming increas-
ingly understood. Dephosphorylation of Cx43 seems to be associated
with the loss and lateralization of Cx43 in monocrotaline-induced
pulmonary hypertension in rats as well as after TAC in mice.94,97 To
determinewhetherCx43phosphorylationwas responsible for gap junc-
tion remodelling, Remo et al.98 generated transgenic knock-in mice
in which phosphomimetic glutamic acids replaced three serines in the
C-terminal domain of Cx43. These serines are known to be phosphory-
latedby casein kinase1d and toplay a role in gap junction assembly. Inter-
estingly, thesemicewere resistant to gap junction remodelling afterTAC
and were less susceptible to the induction of ventricular arrhythmias,
indicating that dephosphorylation of Cx43 is necessary for the remodel-
ling of gap junctions after increased mechanical stretch.
The response to pharmacological blockers of the renin–angiotensin–
aldosterone system also appears to be different between in vitro and
in vivo studies. As mentioned above, Ang II increases Cx43 expression
in vitro, and thiseffect isblockedby losartan. Incontrast, losartanprevented
Cx43 remodelling in rats after TAC,93 and spironolactone prevented or
reversed dephosphorylation and lateralization of Cx43 in mice subjected
to TAC.94 It is thus tempting to speculate that AT1 receptor antagonists
and mineralocorticoid receptor antagonists may have a differential
effect depending on the stage of the disease.
It is now increasingly recognized thatCx43 is part of a largermultimo-
lecular complex involving several typesof intercellular junctionproteins.
Figure2 Ultrastructure of the cardiac intercalated disc. Left: transmission electronmicroscopy image of adultmurine heart showing the close juxtapos-
itionof adesmosome toa gap junction.Right: schematic drawingof potential interactionbetweenplakophilin-2 andCx43at the intercalateddisc.D, desmo-
some; GJ, gap junction; DSG2, desmoglein-2; DSC2, desmocollin-2; PKP2, plakophilin-2; PG, plakoglobin; DP, desmoplakin. Electron microscopy image
reproduced from Delmar and Liang111 with permission from Elsevier.
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In fact, a recent study of adult sheep subjected to pulmonary hyperten-
sion demonstrated that in addition to Cx43, N-cadherin and desmo-
somal proteins (plakoglobin, desmocollin, desmoglein, desmoplakin,
and plakophilin-2)were also remodelled to the lateralmembrane of car-
diomyocytes.99 The lateralization of Cx43 andmechanical junctionswas
associated with the microtubule-associated protein EB1 and the kinesin
proteinKif5b, suggesting that the redistributionof these intercalateddisc
proteins is mediated by microtubule-dependent trafficking.
9. Effect of changes in the
composition of myocardial
mechanical junctions on connexins
Proper electrical andmechanical coupling between cardiomyocytes are
crucial for a normal functionof the heart. Alterations of bothmechanical
junction proteins and gap junction proteins are a prominent feature in
many forms of heart disease such as ischaemia, hypertrophy, and
various cardiomyopathies. There is growing evidence that the different
junctional complexes at the intercalated disc behave in an integrated
manner. Early in vitro studies of gap junction formation showed that pre-
venting adherens junction formation in a tumour cell line through neu-
tralizing antibodies impaired the assembly of gap junctions.91 As the
formation of adherens junctions at the intercalated disc always precedes
Cx43 gap junction formation in cardiomyocytes,89 it seems likely that
any disease process involving adherens junctions would in turn disrupt
Cx43 gap junctions. Similarly, disruption of desmosomes by silencing
one of its components, PKP2, leads to a decrease and an internalization
of Cx43 in NRVMs.100 In addition, pull-down experiments using tagged
proteins showed thatCx43 and PKP2 could precipitatewith each other.
Recently, it was demonstrated that desmocollin-2 could bind to both
Cx43 and plakoglobin, and could thus function as an adaptor protein
between gap junction and desmosome.101 Therefore, it seems that
gap junctions and desmosomes can interact in several ways, supporting
the concept of a macromolecular complex of electrical and mechanical
junctional proteins.
Several animal models have been used to investigate the conse-
quencesof alteredmechanical junctionson connexins. First, a condition-
al heart-specific deletion of N-cadherin was shown to disrupt the
intercalated disc, with the loss of adherens junctions and desmosomes.
In thismodel,Cx43 (andCx40 in the atria)was rapidlydown-regulated in
themyocardium after the loss ofN-cadherin, whichwas associatedwith
a reduction in ventricular conduction velocity.102,103 A whole class of
proteins provides a mechanical link between the adherens junction or
the desmosome and the cytoskeleton (actin filaments or intermediate
filaments, respectively). Interestingly, alterations in these proteins also
affect Cx43. For instance, deletion of the gene coding for aT-catenin,
which bindsb-catenin to actin,was shown to reduceCx43 and PKP2ex-
pression in cardiomyocytes.104 b-Catenin and plakoglobin, two other
adaptor proteins, also affect Cx43. They both connect the adherens
junction to actin filaments and seem to be able to substitute for each
other. In addition, plakoglobin also binds to desmosomal cadherins. In
that sense,mice deficient forb-catenin have amuchmilder cardiomyop-
athy than animals lacking plakoglobin, and mice deficient for both
adaptor proteins suffer frommuchmore severedisease. The expression
of Cx43 seemed to parallel the severity of the phenotype, with a step-
wise decrease in Cx43 from the control, to b-catenin-deficient, to
plakoglobin-deficient, and finally to the double knock-out animals.105
Interestingly, this down-regulation of Cx43 preceded the onset of
inducible arrhythmias, suggesting that additional mechanisms are neces-
sary for the occurrence of arrhythmias.
Thus, in vitro, and in animal models, an intact mechanical junction
between cardiomyocytes is necessary for a proper Cx43 expression
and localization. The down-regulation of Cx43 caused by alterations in
the mechanical junctions seems to be an early event in the progression
of disease, and it predates overt arrhythmogenic events in animals. In
humans, arrhythmogenic right ventricular cardiomyopathy (ARVC,
also sometimes referred to as ARVD or AC) is considered a desmo-
somal disorder. Indeed, more than half of patients have a known muta-
tion in one of the five genes coding for desmosomal proteins.
Interestingly, a recent study investigating the expression of various junc-
tional proteins in patients suffering fromARVC showed that both plako-
globin andCx43weredown-regulated in all regionsof theheart fromthe
majority ofARVCpatients, regardless of the underlying genetic disorder
(11 out of 11 patients in Asimaki et al.106 and 14 out of 20 patients in
Noorman et al.107). Other desmosomal proteins, such as desmoplakin
and PKP2, were more variably expressed between patients. It, thus,
appears that remodelling of Cx43 is a consistent feature in patients
with ARVC, which could participate in the arrhythmogenic substrate
of the disease. In fact, it is well known that remodelling of Cx43
occurs early in the progression of the disease, before overt structural
damages.89,108,109 This is in contrast with other cardiac pathologies,
such as ischaemic disease, hypertrophic cardiomyopathy, or dilated
cardiomyopathy, where remodelling of Cx43 appears at later stages
after considerable structural alterations.
Recent studies demonstrate that in addition to Cx43, the major
a-subunit of the cardiac sodium channel, Nav1.5, is also remodelled in
patients suffering from ARVC.107 In vitro studies showed that Nav1.5 is
associatedwithPKP2and that knockdownofPKP2affects theproperties
of the sodium channel and reduces conduction velocity in cultured
cardiomyocytes.110 Thus, in addition to inducing Cx43 remodelling,
alterations in mechanical junction proteins could also affect the
cardiac sodium current. This would constitute an additional mechanism
underlying arrhythmias in ARVC.
In conclusion, physiologicalCx43expression in themyocardium is de-
pendent on the proper expression and localization of mechanical junc-
tion proteins at the intercalated disc. Cx43 is consistently affected in
arrhythmogenic diseases caused by mutations in mechanical junction
proteins.
10. Summary
It has beenwell established that endothelial gap junctions are sensitive to
shear stress, which changes their relative connexin composition. While
Cx37 is up-regulated by HLSS and Cx43 by OSS, arterial Cx40 seems
relatively insensitive to shear stress. These differences in connexin ex-
pression create endothelial communication compartments that may
play a role in disease development, i.e. that may determine location of
atherosclerotic lesions, but that may also participate in physiological
processes such as valve formation. The effect of mechanical stretch as
imposed by increased afterload on the heart is fairly established as
well. Stretch seems to first induce a compensatory increase of Cx43
in cardiomyocytes, which is followed by a reduction and remodelling
of Cx43 and associated mechanical junction proteins. Whether there
is reciprocal regulation between mechanical and gap junctions in ECs
and VSMCs is unclear at this moment. Moreover, with regard to hyper-
tension, the effects on connexins seem to depend very much on the
model studied, and data remain inconsistent even when the same
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model was used. Importantly, connexin expression is normalized by
pharmacologically blocking the renin–angiotensin system in several
models of systemic hypertension, making this an exciting new target
for future drug development.
There is growing interest in the study of the inter-relation between
mechanical forces, mechanical junctions, and connexin expression in
the cardiovascular system. In the heart, the idea that the loss of Cx43
from the intercalated discmay increase the susceptibility to arrhythmias
is quite straightforward. However, the consequences of an increase in
Cx43 expression, as seen in the early stages after increased afterload,
are less obvious.One can hypothesize that in addition to increased elec-
trical coupling, the induction of Cx43 expression could also favour the
transfer of larger molecules such as metabolites, siRNA,2 or miRNA3
between cardiomyocytes that are subjected to increased strain. This
could lead to the homogeneousmyocyte hypertrophy seen in compen-
sated aortic stenosis. Interestingly, Cx43 is also up-regulated in VSMCs
of arteries subjected to hypertension. One could imagine a similar com-
pensatory mechanism in response to increased stretch, leading to
increased resistanceof the arteries tobloodpressure.Regulationof con-
nexins by shear stress seems to be a consistent feature, independently of
the vascular bed. Whereas a function for Cx37 induction has been
demonstrated in lymphatic valve development, the consequences of
shear stress-dependent connexin regulation in blood vessels or in
other regions of lymphatic vessels are only hypothetical so far. The
main limitation resides in identifying the nature of themolecules diffusing
through endothelial gap junctions. It is thought provoking that Cx43 and
Cx37, which form gap junction channels with very different permeabil-
ities, are inversely regulated by shear stress in ECs. It suggests that shear
stress patterns, by modulating the ratio of Cx37 and Cx43, tightly
regulate the permeability of endothelial gap junctions to distinct
molecules. The precise identification of such molecules would greatly
advance the understanding of the role of the synchronization induced
by mechanotransduction.
Finally, long-standing questions remain as to the nature of the mes-
sages, the relevance of connexin diversity, and their importance on
disease initiation or progression. Connexins have been seen as exciting
pharmacological targets for years and yet, they have been hidden from
the touch of selective drugs. Although the contribution of connexins
to the maintenance of normal cellular functions is now relatively well
understood, the specific contribution of connexins to disease is less
clear. Whether it is in the blood vessels or in the heart, there is
growing evidence that cross-talk of connexins with molecules involved
in mechanical events is not coincidental or irrelevant, but rather the
resultof the fact that thesemolecules all livewithinmolecularcomplexes
where connexins are not only makers of gap junctions or, say,
plakophilin-2 a maker of desmosomes. They are all part of a
protein-interacting network that at the end regulates adhesion, cell–
cell coupling, and excitability in the cardiovascular system.
Funding
This work was supported by grants from the Swiss National Science Foun-
dation (310030_143343/1 and CRSII3_141811/1 to B.R.K.) and from the
Fondation Leenaards (to B.R.K.). In addition, this work was supported by
grants from the National Institutes of Health (O1-HL106632 and
RO1-GM57691 to M.D.) and from the Leducq Foundation Transatlantic
Network (to M.D.).
Conflict of interest: none declared.
References
1. Saez JC, BerthoudVM,BranesMC,MartinezAD,Beyer EC. Plasmamembranechannels
formed by connexins: their regulation and functions. Physiol Rev 2003;83:1359–1400.
2. Valiunas V, Polosina YY,Miller H, Potapova IA, Valiuniene L, Doronin S et al. Connexin-
specific cell-to-cell transfer of short interfering RNA by gap junctions. J Physiol 2005;
568(Pt 2):459–468.
3. Lim PK, Bliss SA, Patel SA, Taborga M, Dave MA, Gregory LA et al. Gap junction-
mediated import ofmicroRNA frombonemarrowstromal cells can elicit cell cycle qui-
escence in breast cancer cells. Cancer Res 2011;71:1550–1560.
4. Neijssen J,HerbertsC,Drijfhout JW,Reits E, Janssen L,Neefjes J.Cross-presentationby
intercellular peptide transfer through gap junctions. Nature 2005;434:83–88.
5. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels.
Nat Rev Mol Cell Biol 2003;4:285–294.
6. Kwak BR, Mulhaupt F, Veillard N, Gros DB, Mach F. Altered pattern of vascular con-
nexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002;22:
225–230.
7. van Kempen MJ, Jongsma HJ. Distribution of connexin37, connexin40 and connexin43
in the aorta and coronary artery of several mammals. Histochem Cell Biol 1999;112:
479–486.
8. Yeh HI, Chang HM, LuWW, Lee YN, Ko YS, Severs NJ et al. Age-related alteration of
gap junctiondistributionandconnexinexpression in rat aortic endothelium. JHistochem
Cytochem 2000;48:1377–1389.
9. Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, Foglia BF et al. Con-
nexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med
2006;12:950–954.
10. Chadjichristos CE, Scheckenbach KE, van Veen TA, Richani Sarieddine MZ, deWit C,
Yang Z et al. Endothelial-specific deletion of connexin40 promotes atherosclerosis by
increasing CD73-dependent leukocyte adhesion. Circulation 2010;121:123–131.
11. Kwak BR, Veillard N, Pelli G, Mulhaupt F, James RW, Chanson M et al. Reduced con-
nexin43expression inhibits atherosclerotic lesion formation in low-density lipoprotein
receptor-deficient mice. Circulation 2003;107:1033–1039.
12. Alonso F, Boittin FX, Beny JL, Heafliger JA. Loss of connexin40 is associated with
decreased endothelium-dependent relaxations and eNOS levels in the mouse aorta.
Am J Physiol Heart Circ Physiol 2010;299:H1365–H1373.
13. Pfenniger A, Derouette JP, Verma V, Lin X, Foglia B, Coombs W et al. Gap junction
protein Cx37 interacts with endothelial nitric oxide synthase in endothelial cells. Arter-
ioscler Thromb Vasc Biol 2010;30:827–834.
14. Angelillo-ScherrerA, Fontana P, Burnier L, Roth I, Sugamele R, BrissetA et al. Connexin
37 limits thrombus propensity by downregulating platelet reactivity. Circulation 2011;
124:930–939.
15. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y et al. The im-
portance of the hyperpolarizing mechanism increases as the vessel size decreases in
endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharma-
col 1996;28:703–711.
16. Looft-WilsonRC, BillaudM, Johnstone SR, StraubAC, Isakson BE. Interaction between
nitric oxide signaling and gap junctions: effects on vascular function.BiochimBiophys Acta
2011;1818:1895–1902.
17. Sandow SL, Senadheera S, Bertrand PP, Murphy TV, Tare M. Myoendothelial contacts,
gap junctions, andmicrodomains: anatomical links to function?Microcirculation2012;19:
403–415.
18. SandowSL,HillCE. Incidenceofmyoendothelial gap junctions in theproximal anddistal
mesenteric arteries of the rat is suggestive of a role in endothelium-derived
hyperpolarizing factor-mediated responses. Circ Res 2000;86:341–346.
19. Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC. Involvement of myoen-
dothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor.
Circ Res 2002;90:1108–1113.
20. Inai T, Shibata Y. Heterogeneous expression of endothelial connexin (Cx) 37, Cx40,
and Cx43 in rat large veins. Anat Sci Int 2009;84:237–245.
21. ChangCJ,Wu LS, Hsu LA, ChangGJ, ChenCF, YehHI et al. Differential endothelial gap
junction expression in venous vessels exposed to different hemodynamics. J Histochem
Cytochem 2010;58:1083–1092.
22. Kanady JD, Dellinger MT, Munger SJ, Witte MH, Simon AM. Connexin37 and Con-
nexin43 deficiencies in mice disrupt lymphatic valve development and result in lymph-
atic disorders including lymphedema and chylothorax. Dev Biol 2011;354:253–266.
23. Sabine A, Agalarov Y, Maby-El Hajjami H, Jaquet M, Hagerling R, Pollmann C et al.
Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and cal-
cineurin during lymphatic-valve formation. Dev Cell 2012;22:430–445.
24. Munger SJ, Kanady JD, Simon AM. Absence of venous valves in mice lacking Con-
nexin37. Dev Biol 2013;373:338–348.
25. Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and connexin
expression in diseased myocardium. Cardiovasc Res 2008;80:9–19.
26. Garcia-DoradoD,Rodriguez-SinovasA, Ruiz-MeanaM.Gap junction-mediated spread
of cell injury and deathduringmyocardial ischemia-reperfusion.Cardiovasc Res2004;61:
386–401.
27. van Kempen MJ, ten Velde I, Wessels A, Oosthoek PW, Gros D, Jongsma HJ et al. Dif-
ferential connexin distribution accommodates cardiac function in different species.
Microsc Res Tech 1995;31:420–436.
M.J. Meens et al.312
28. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular patho-
physiology. Nat Clin Pract Cardiovasc Med 2009;6:16–26.
29. BoonRA,HorrevoetsAJ. Key transcriptional regulators of the vasoprotective effects of
shear stress. Hamostaseologie 2009;29:39–40. 41–3.
30. Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological
basis and clinical perspectives. Physiol Rev 2011;91:327–387.
31. Van der Heiden K, Cuhlmann S, Luong le A, Zakkar M, Evans PC. Role of nuclear factor
kappaB in cardiovascular health and disease. Clin Sci (Lond) 2010;118:593–605.
32. BoscoD,Haefliger JA, Meda P. Connexins: keymediators of endocrine function. Physiol
Rev 2011;91:1393–1445.
33. Pfenniger A, Chanson M, Kwak BR. Connexins in atherosclerosis. Biochim Biophys Acta
2013;1828:157–166.
34. Weidmann S. The electrical constants of Purkinje fibres. J Physiol 1952;118:348–360.
35. Johnstone S, Isakson B, Locke D. Biological and biophysical properties of vascular con-
nexin channels. Int Rev Cell Mol Biol 2009;278:69–118.
36. Gabriels JE, Paul DL. Connexin43 is highly localized to sites of disturbed flow in rat
aortic endothelium but connexin37 and connexin40 are more uniformly distributed.
Circ Res 1998;83:636–643.
37. Inai T, Mancuso MR, McDonald DM, Kobayashi J, Nakamura K, Shibata Y. Shear
stress-inducedupregulationof connexin43expression in endothelial cells on upstream
surfaces of rat cardiac valves. Histochem Cell Biol 2004;122:477–483.
38. Cowan DB, Lye SJ, Langille BL. Regulation of vascular connexin43 gene expression by
mechanical loads. Circ Res 1998;82:786–793.
39. DePaola N, Davies PF, PritchardWF Jr., Florez L, Harbeck N, Polacek DC. Spatial and
temporal regulationof gap junction connexin43 in vascular endothelial cells exposed to
controlled disturbed flows in vitro. Proc Natl Acad Sci USA 1999;96:3154–3159.
40. Kwak BR, Silacci P, StergiopulosN, HayozD,Meda P. Shear stress and cyclic circumfer-
ential stretch, but not pressure, alter connexin43 expression in endothelial cells. Cell
Commun Adhes 2005; 12:261–270.
41. Alonso F, KrattingerN,Mazzolai L, SimonA,WaeberG,Meda P et al. An angiotensin II-
and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries tar-
geted by renin-dependent hypertension. Cardiovasc Res 2010;87:166–176.
42. BaoX, Clark CB, Frangos JA. Temporal gradient in shear-induced signaling pathway: in-
volvement of MAP kinase, c-fos, and connexin43. Am J Physiol Heart Circ Physiol 2000;
278:H1598–H1605.
43. Conway DE, Williams MR, Eskin SG, McIntire LV. Endothelial cell responses to ather-
oprone flow are driven by two separate flow components: low time-average shear
stress and fluid flow reversal. Am J Physiol Heart Circ Physiol 2010;298:H367–H374.
44. Kefaloyianni E, Coetzee WA. Transcriptional remodeling of ion channel subunits by
flow adaptation in human coronary artery endothelial cells. J Vasc Res 2011;48:
357–367.
45. PasseriniAG, PolacekDC, ShiC, FrancescoNM,Manduchi E,GrantGRet al. Coexisting
proinflammatoryandantioxidative endothelial transcriptionprofiles in adisturbedflow
region of the adult porcine aorta. Proc Natl Acad Sci USA 2004;101:2482–2487.
46. White SJ, Hayes EM, Lehoux S, Jeremy JY, Horrevoets AJ, NewbyAC.Characterization
of the differential response of endothelial cells exposed to normal and elevated laminar
shear stress. J Cell Physiol 2011;226:2841–2848.
47. Pfenniger A, Wong C, Sutter E, Chulmann S, Dunoyer-Geindre S, Mach F et al. Shear
stress modulates the expression of the atheroprotective protein Cx37 in endothelial
cells. J Mol Cell Cardiol 2012;53:299–309.
48. Cheng C, vanHaperen R, deWaardM, vanDamme LC, Tempel D, Hanemaaijer L et al.
Shear stress affects the intracellular distribution of eNOS: direct demonstration by a
novel in vivo technique. Blood 2005;106:3691–3698.
49. Vorderwulbecke BJ, Maroski J, Fiedorowicz K, Da Silva-Azevedo L, Marki A, Pries AR
et al. Regulation of endothelial connexin40 expression by shear stress. Am J Physiol
Heart Circ Physiol 2012;302:H143–H152.
50. Brisset AC, Isakson BE, Kwak BR. Connexins in vascular physiology and pathology. Anti-
oxid Redox Signal 2009;11:267–282.
51. Buschmann I, Pries A, Styp-Rekowska B, Hillmeister P, Loufrani L, Henrion D et al. Pul-
satile shear and Gja5 modulate arterial identity and remodeling events during flow-
driven arteriogenesis. Development 2010;137:2187–2196.
52. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. Heart
disease and stroke statistics–2012 update: a report from the American Heart Associ-
ation. Circulation 2012;125:e2–e220.
53. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al. Guidelines
for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:
1219–1263.
54. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al. Guidelines
for the diagnosis and treatment of pulmonary hypertension: the Task Force for the
Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Car-
diology (ESC) and the European Respiratory Society (ERS), endorsed by the Inter-
national Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:
2493–2537.
55. Shah SJ. Pulmonary hypertension. JAMA 2012;308:1366–1374.
56. BadeschDB, RaskobGE, Elliott CG, KrichmanAM, FarberHW, Frost AE et al. Pulmon-
ary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest
2010;137:376–387.
57. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V et al. Pulmonary
arterial hypertension in France: results from a national registry. Am J Respir Crit Care
Med 2006;173:1023–1030.
58. Haefliger JA, Castillo E, Waeber G, Aubert JF, Nicod P, Waeber B et al. Hypertension
differentially affects the expression of the gap junction protein connexin43 in cardiac
myocytes and aortic smooth muscle cells. Adv Exp Med Biol 1997;432:71–82.
59. Haefliger JA, Castillo E,Waeber G, Bergonzelli GE, Aubert JF, Sutter E et al. Hyperten-
sion increases connexin43 in a tissue-specific manner. Circulation 1997;95:1007–14.
60. Watts SW, Webb RC. Vascular gap junctional communication is increased in
mineralocorticoid-salt hypertension. Hypertension 1996;28:888–893.
61. Haefliger JA, Demotz S, Braissant O, Sutter E, Waeber B, Nicod P et al. Connexins 40
and 43 are differentially regulated within the kidneys of rats with renovascular hyper-
tension. Kidney Int 2001;60:190–201.
62. Haefliger JA, Meda P, Formenton A,Wiesel P, Zanchi A, Brunner HR et al. Aortic con-
nexin43 is decreasedduringhypertension inducedby inhibitionof nitric oxide synthase.
Arterioscler Thromb Vasc Biol 1999;19:1615–1622.
63. Yeh HI, Lee PY, Su CH, Tian TY, Ko YS, Tsai CH. Reduced expression of endothelial
connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment.
Am J Hypertens 2006;19:129–135.
64. Rummery NM, McKenzie KU, Whitworth JA, Hill CE. Decreased endothelial size and
connexin expression in rat caudal arteries during hypertension. J Hypertens 2002;20:
247–253.
65. Rummery NM, Grayson TH, Hill CE. Angiotensin-converting enzyme inhibition
restores endothelial but not medial connexin expression in hypertensive rats.
J Hypertens 2005;23:317–328.
66. Kansui Y, Fujii K, Nakamura K, Goto K, Oniki H, Abe I et al. Angiotensin II receptor
blockade corrects altered expression of gap junctions in vascular endothelial cells
from hypertensive rats. Am J Physiol Heart Circ Physiol 2004;287:H216–H224.
67. Braunstein TH, Sorensen CM, Holstein-Rathlou NH. Connexin abundance in resist-
ance vessels from the renal microcirculation in normo- and hypertensive rats. APMIS
2009;117:268–276.
68. KrattingerN,CapponiA,Mazzolai L, Aubert JF,CailleD,Nicod P et al. Connexin40 reg-
ulates renin production and blood pressure. Kidney Int 2007;72:814–822.
69. Kurtz L, Schweda F, de Wit C, Kriz W, Witzgall R, Warth R et al. Lack of connexin 40
causes displacement of renin-producing cells from afferent arterioles to the extraglo-
merular mesangium. J Am Soc Nephrol 2007;18:1103–1111.
70. JobsA, Schmidt K, SchmidtVJ, Lubkemeier I, vanVeenTA, KurtzA et al. DefectiveCx40
maintains Cx37 expression but intactCx40 is crucial for conducted dilations irrespect-
ive of hypertension. Hypertension 2012;60:1422–1429.
71. Wagner C, de Wit C, Kurtz L, Grunberger C, Kurtz A, Schweda F. Connexin40 is es-
sential for the pressure control of renin synthesis and secretion. Circ Res 2007;100:
556–563.
72. GollobMH, JonesDL, KrahnAD,Danis L,GongXQ, ShaoQ et al. Somaticmutations in
the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006;354:2677–2688.
73. Lubkemeier I, Machura K, Kurtz L, Neubauer B, Dobrowolski R, Schweda F et al. The
connexin 40 A96S mutation causes renin-dependent hypertension. J Am Soc Nephrol
2011;22:1031–1040.
74. Kanter HL, Saffitz JE, Beyer EC. Molecular cloning of two human cardiac gap junction
proteins, connexin40 and connexin45. J Mol Cell Cardiol 1994;26:861–868.
75. Firouzi M, Kok B, SpieringW, Busjahn A, Bezzina CR, Ruijter JM et al. Polymorphisms in
human connexin40 gene promoter are associated with increased risk of hypertension
in men. J Hypertens 2006;24:325–330.
76. PfennigerA, van der LaanSW, Foglia B,Dunoyer-Geindre S,Haefliger JA,Winnik S et al.
Lack of association between connexin40 polymorphisms and coronary artery disease.
Atherosclerosis 2012;222:148–153.
77. deWitC,Roos F, Bolz SS, PohlU. Lackof vascular connexin40 is associatedwith hyper-
tension and irregular arteriolar vasomotion. Physiol Genomics 2003;13:169–177.
78. deWit C, Roos F, Bolz SS, Kirchhoff S, KrugerO,Willecke K et al. Impaired conduction
of vasodilation along arterioles in connexin40-deficient mice. Circ Res 2000;86:
649–655.
79. FigueroaXF, Paul DL, Simon AM, Goodenough DA, Day KH, DamonDN et al. Central
role of connexin40 in the propagation of electrically activated vasodilation in mouse
cremasteric arterioles in vivo. Circ Res 2003;92:793–800.
80. Zhuang J, YamadaKA, Saffitz JE, Kleber AG. Pulsatile stretch remodels cell-to-cell com-
munication in cultured myocytes. Circ Res 2000;87:316–322.
81. Wang TL, Tseng YZ, Chang H. Regulation of connexin 43 gene expression by cyclical
mechanical stretch in neonatal rat cardiomyocytes. Biochem Biophys Res Commun
2000;267:551–557.
82. Shyu KG, Chen CC, Wang BW, Kuan P. Angiotensin II receptor antagonist blocks the
expression of connexin43 induced by cyclical mechanical stretch in cultured neonatal
rat cardiac myocytes. J Mol Cell Cardiol 2001;33:691–698.
83. Simpson DG, Majeski M, Borg TK, Terracio L. Regulation of cardiac myocyte protein
turnover and myofibrillar structure in vitro by specific directions of stretch. Circ Res
1999;85:e59–e69.
84. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates
stretch-induced hypertrophy of cardiac myocytes in vitro. Cell, 1993;75:977–984.
Connexins and mechanotransduction 313
85. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction
pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mech-
anism. EMBO J 1993;12:1681–1692.
86. SekoY, TakahashiN, ShibuyaM, Yazaki Y. Pulsatile stretch stimulates vascular endothe-
lial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem Biophys
Res Commun 1999;254:462–465.
87. RuwhofC, vanWamel AE, Egas JM, van der Laarse. Cyclic stretch induces the releaseof
growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibro-
blasts.Mol Cell Biochem 2000;208:89–98.
88. Pimentel RC, YamadaKA, KleberAG, Saffitz JE. Autocrine regulation ofmyocyte Cx43
expression by VEGF. Circ Res, 2002;90:671–677.
89. Saffitz JE, Kleber AG. Effects of mechanical forces andmediators of hypertrophy on re-
modeling of gap junctions in the heart. Circ Res 2004;94:585–591.
90. McCain ML, Lee H, Aratyn-Schaus Y, Kleber AG, Parker KK. Cooperative coupling of
cell-matrix and cell-cell adhesions in cardiac muscle. Proc Natl Acad Sci USA 2012;109:
9881–9886.
91. Meyer RA, Laird DW, Revel JP, Johnson RG. Inhibition of gap junction and adherens
junction assembly by connexin and A-CAM antibodies. J Cell Biol 1992;119:179–189.
92. Uzzaman M, Honjo H, Takagishi Y, Emdad L, Magee AI, Severs NJ et al. Remodeling of
gap junctional coupling in hypertrophied right ventricles of rats with
monocrotaline-induced pulmonary hypertension. Circ Res 2000;86:871–878.
93. Emdad L, UzzamanM, Takagishi Y, Honjo H, Uchida T, SeversNJ et al. Gap junction re-
modeling in hypertrophied left ventricles of aortic-banded rats: prevention by angio-
tensin II type 1 receptor blockade. J Mol Cell Cardiol 2001;33:219–231.
94. Qu J, Volpicelli FM,Garcia LI, SandeepN,Zhang J,Marquez-RosadoL et al. Gap junction
remodeling and spironolactone-dependent reverse remodeling in the hypertrophied
heart. Circ Res 2009;104:365–371.
95. Kostin S, Dammer S, Hein S, KlovekornWP, Bauer EP, Schaper J. Connexin 43 expres-
sion and distribution in compensated and decompensated cardiac hypertrophy in
patients with aortic stenosis. Cardiovasc Res 2004;62:426–436.
96. BenoistD, StonesR,DrinkhillMJ, BensonAP,YangZ,CassanCet al. Cardiac arrhythmia
mechanisms in rats with heart failure induced by pulmonary hypertension. American
journal of physiology. Heart Circ Physiol, 2012;302:H2381–H2395.
97. Sasano C, Honjo H, Takagishi Y, Uzzaman M, Emdad L, Shimizu A et al. Internalization
anddephosphorylationof connexin43 inhypertrophied right ventriclesof ratswithpul-
monary hypertension. Circ J 2007;71:382–389.
98. RemoBF,Qu J, Volpicelli FM,Giovannone S, ShinD, Lader J et al. Phosphatase-resistant
gap junctions inhibit pathological remodeling and prevent arrhythmias. Circ Res 2011;
108:1459–1466.
99. Chkourko HS, Guerrero-Serna G, Lin X, Darwish N, Pohlmann JR, Cook KE et al. Re-
modeling of mechanical junctions and of microtubule-associated proteins accompany
cardiac connexin43 lateralization. Heart Rhythm 2012;9:1133–1140 e6.
100. Oxford EM, Musa H, Maass K, CoombsW, Taffet SM, Delmar M. Connexin43 remod-
eling caused by inhibition of plakophilin-2 expression in cardiac cells. Circ Res 2007;101:
703–711.
101. Gehmlich K, Lambiase PD, Asimaki A, Ciaccio EJ, Ehler E, Syrris P et al. A novel
desmocollin-2 mutation reveals insights into the molecular link between desmosomes
and gap junctions. Heart Rhythm 2011;8:711–718.
102. Kostetskii I, Li J, Xiong Y, Zhou R, Ferrari VA, Patel VV et al. Induced deletion of the N-
cadherin gene in the heart leads to dissolutionof the intercalated disc structure.Circ Res
2005;96:346–354.
103. Li J, Patel VV, Kostetskii I, Xiong Y, Chu AF, Jacobson JT et al. Cardiac-specific loss of
N-cadherin leads to alteration in connexins with conduction slowing and arrhythmo-
genesis. Circ Res 2005;97:474–481.
104. Li J,Goossens S, vanHengel J,GaoE,Cheng L, TybergheinK et al. Lossof alphaT-catenin
alters the hybrid adhering junctions in the heart and leads to dilated cardiomyopathy
and ventricular arrhythmia following acute ischemia. J Cell Sci 2012;125(Pt 4):
1058–1067.
105. Swope D, Cheng L, Gao E, Li J, Radice GL. Loss of cadherin-binding proteins beta-
catenin and plakoglobin in the heart leads to gap junction remodeling and arrhythmo-
genesis.Mol Cell Biol 2012;32:1056–1067.
106. Asimaki A, TandriH, HuangH,HalushkaMK,Gautam S, BassoC et al. A newdiagnostic
test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 2009;360:
1075–1084.
107. NoormanM,Hakim S, Kessler E, Groeneweg J, CoxMG,Asimaki A et al. Remodeling of
the cardiac sodium channel, connexin 43, and plakoglobin at the intercalated disk in
patients with arrhythmogenic cardiomyopathy. Heart Rhythm 2012.
108. Kaplan SR, Gard JJ, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A
et al. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardio-
myopathy due to a deletion in plakoglobin (Naxos disease).Heart Rhythm2004;1:3–11.
109. Gomes J, FinlayM,AhmedAK,Ciaccio EJ, AsimakiA, Saffitz JE et al. Electrophysiological
abnormalities precede overt structural changes in arrhythmogenic right ventricular
cardiomyopathy due to mutations in desmoplakin-A combined murine and human
study. Eur Heart J 2012;33:1942–1953.
110. Sato PY, Musa H, Coombs W, Guerrero-Serna G, Patino GA, Taffet SM et al. Loss of
plakophilin-2 expression leads to decreased sodium current and slower conduction
velocity in cultured cardiac myocytes. Circ Res 2009;105:523–526.
111. DelmarM, Liang FX. Connexin43 and the regulationof intercalated disc function.Heart
Rhythm 2012;9:835–838.
112. Tsai ML,Watts SW, Loch-Caruso R,Webb RC. The role of gap junctional communica-
tion in contractile oscillations in arteries from normotensive and hypertensive rats.
J Hypertens 1995;13:1123–1133.
M.J. Meens et al.314
